Mitsubishi Tanabe Pharma Corporation v. Cipla USA, Inc. et al
| Mitsubishi Tanabe Pharma Corporation |
| Cipla USA, Inc. and Cipla Limited |
| 1:2023cv00759 |
| July 12, 2023 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 8, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Remark: The September 12, 2023 Telephonic Scheduling Conference is canceled per the filing of the Proposed Scheduling Order with no areas of dispute. (nmf) |
| Filing 17 Joint PROPOSED ORDER -- [Proposed] Scheduling Order -- re #16 Order Setting Scheduling Conference, by Mitsubishi Tanabe Pharma Corporation. (Attachments: #1 Cover Letter to The Honorable Colm F. Connolly)(Tigan, Jeremy) |
Filing 16
Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 9/12/2023 at 10:00 AM before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 8/7/2023. (nmf)
|
| Filing 15 MOTION for Pro Hac Vice Appearance of Attorney Alexander Alfano, Uma N. Everett, Robert E. Neimeier, Dennies Varughese and Marsha Rose Gallentine - filed by Cipla Limited, Cipla USA, Inc.. (Dorsney, Kenneth) |
|
SO ORDERED, re #15 MOTION for Pro Hac Vice Appearance of Attorney Alexander Alfano, Uma N. Everett, Robert E. Neimeier, Dennies Varughese and Marsha Rose Gallentine, filed by Cipla Limited, Cipla USA, Inc. Ordered by Judge Colm F. Connolly on 8/7/2023. (kmd)
|
| Filing 14 NOTICE of Change of Address by Kenneth Laurence Dorsney (Dorsney, Kenneth) |
| Filing 13 NOTICE OF SERVICE of ANDA Production filed by Cipla Limited, Cipla USA, Inc..(Dorsney, Kenneth) |
| Pro Hac Vice Attorney Donald R. McPhail and Andrew M. Ollis for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cipla Limited, Corporate Parent Cipla (EU Limited), Corporate Parent InvaGen Pharmaceuticals, Inc., for Cipla USA, Inc. filed by Cipla USA, Inc.. (Dorsney, Kenneth) |
| Filing 11 ANSWER to #1 Complaint by Cipla Limited, Cipla USA, Inc..(Dorsney, Kenneth) |
| Pro Hac Vice Attorney Yuki Onoe for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Pro Hac Vice Attorney Frank J. West for Mitsubishi Tanabe Pharma Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 10 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Ollis, Yuki Onoe, Donald R. McPhail, Frank J. West, Akihiro Yamazaki and Nao Takada filed by Mitsubishi Tanabe Pharma Corporation. Signed by Judge Colm F. Connolly on 7/19/2023. (nmf)
|
| Filing 9 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Ollis, Yuki Onoe, Donald R. McPhail, Frank J. West, Akihiro Yamazaki and Nao Takada - filed by Mitsubishi Tanabe Pharma Corporation. (Tigan, Jeremy) |
| Filing 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Cipla Limited on July 12, 2023, filed by Mitsubishi Tanabe Pharma Corporation. (Tigan, Jeremy) |
| Filing 7 SUMMONS Returned Executed by Mitsubishi Tanabe Pharma Corporation.Cipla USA, Inc. served on 7/12/2023, answer due 8/2/2023. (Tigan, Jeremy) |
| Filing 6 Summons Issued as to Cipla Limited and Cipla USA, Inc. on 7/12/2023. (Attachments: #1 Summons Issued Cipla Limited)(jfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mitsubishi Chemical Group Corporation for Mitsubishi Tanabe Pharma Corporation filed by Mitsubishi Tanabe Pharma Corporation. (jfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,987,341 B2; 11,241,416 B2; 11,478,450 B2. (jfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 31, 2023. Date of Expiration of Patent: November 1, 2039.Thirty Month Stay Deadline: 11/30/2025. (jfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Cipla Limited and Cipla USA, Inc. (Filing fee $ 402, receipt number ADEDC-4176608.) - filed by Mitsubishi Tanabe Pharma Corporation. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(jfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
